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Abstract
The issue of surgical treatment of patients with generalized periodontitis and osteopenia is particularly topical. Numerous
studies have confirmed the benefits of surgical treatment procedures using osteoplastic material to stimulate repair process
of periodontal tissues.
The objective of the research was to improve the effectiveness of surgical treatment of patients with generalized periodontitis
and osteopenia through the combined use of osteoplastic material and antiresorptive drugs.
Materials and methods. Ninety-three patients underwent treatment and clinical observation. The patients were divided into
3 groups. Group I included 20 patients who underwent surgical treatment according to conventional procedure. Group II
included 25 patients who underwent surgical treatment with topical application of osteoplastic material “Easy Graft”. Surgical
treatment in Group III (26 patients) was conducted using osteoplastic material “Easy Graft” and antiresorptive drug “Bonviva”.
The control group consisted of 22 apparently healthy individuals.
Conclusions. The obtained results indicated that surgical treatment with the combined use of osteoplastic material “Easy
Graft” and antiresorptive drug “Bonviva” leads to process stabilization being confirmed by clinical study indices both in early
and in remote postoperative period.
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Problem statement and analysis of the
recent research
Generalized periodontitis (GP) is a common disease. Its fre-
quency increases with age and is characterized by inflamma-
tory and resorption and destructive processes in the patient’s
periodontal tissues. Numerous factors causing generalized
periodontitis include osteopenia and jaw bony tissue osteo-
porosis [1, 2]. The study of the relationship between metabolic
disorders of skeletal system and periodontal diseases is es-
sential in order to determine the role of systemic factors of
bone metabolism regulations and to ground pharmacological
improvement of dystrophic destructive processes in the bony
tissue [3]. Jaw bony tissue performs the supporting function
of periodontal tissues and is also a reserve depot of minerals as
part of the skeletal system of the body [4]. Surgical treatment
is an integral part of GP comprehensive treatment. Surgical
treatment of periodontal disease is the most effective method
of obtaining stable positive results [5, 6, 7].
Surgical treatment of periodontal disease yet does not pro-
vide sufficient conditions to eliminate the pathological process
in the bone structure of jaw bones as skeleton mineral density
and the features of bony tissue metabolism in people of dif-
ferent age and sex is not taken into account [8, 9]. Numerous
studies have confirmed the benefits of surgical treatment pro-
cedures using osteoplastic material to stimulate repair process
of periodontal tissues [10, 11].
The objective of the research was to improve the effec-
tiveness of surgical treatment of patients with generalized
periodontitis and osteopenia through the combined use of
osteoplastic material and antiresorptive drugs.
1. Materials and methods
Ninety-three patients at the age of 31 to 69 were examined,
treated and underwent clinical observation during the research.
Patients with somatic diseases in the decompensation stage,
malignant neoplasms, decompensated diabetes, and infectious
diseases were excluded from the research. Patients were di-
vided into three groups. Group I included 20 patients with GP
and osteopenia who underwent surgical treatment according
to conventional procedure. Group II included 25 patients with
GP and osteopenia who underwent surgical treatment with lo-
cal application of osteoplastic material ”Easy Graft”. Surgical
treatment in Group III (26 patients with GP and osteopenia)
was conducted using osteoplastic material ”Easy Graft” and
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antiresorptive drug ”Bonviva”. The control group consisted
of 22 apparently healthy individuals.
All patients with GP and osteopenia underwent classical
Cieszyn´ski-Widmann-Neumann surgery for the periodontium
of the appropriate jaw. Mouth cavity was irrigated with anti-
septic solutions and anesthesia was performed with Sol. Ubis-
tesini 4%. Two vertical incisions from the gingival margin to
transitory fold of the pathological process margins and hor-
izontal incisions along the gingival margin from labial and
lingual (palatal) sides were performed. Modified gingival
margins with the width of about 2 mm were cut with scissors.
Granulation tissue, dental plaque was removed. Bone edge
was treated, and tooth root was polished. Bone cavities were
filled with ”Easy Graft” material. ”Easy Graft” hardened and
acquired a shape of monolithic implant, but a porous one
when combined with oral fluids. Mucoperiosteal flap was
mobilized, cast in place, and stitched in the interdental spaces.
Antiresorptive drug ”Bonviva” and background drug therapy,
namely Azithromycin-Astrapharm 500 mg at a dose of 1 cap-
sule for 3 days (course dose of 1.5 g), Loratadine at a dose of
1 tablet (10 mg) once a day during 10 days and Laktovit Forte
at a dose of 1 capsule twice a day for 10 days were prescribed.
Patients of Group I, who were treated with background
drug therapy, underwent classical Cieszyn´ski-Widmann-Neu-
mann surgery for the periodontium of the appropriate jaw,
namely 18 surgeries on the lower jaw and 2 surgeries on the
upper jaw. One surgery was performed in 16 (80.0%) patients,
two surgeries were performed in 2 (20.0%) patient.
All patients of Group II, who were treated with back-
ground drug therapy using osteoplastic material ”Easy Graft”
in the comprehensive treatment, underwent classical Cieszyn´-
ski-Widmann-Neumann surgery for the periodontium of the
appropriate jaw, namely 20 surgeries on the lower jaw and 5
surgeries on the upper jaw. One surgery was performed in 19
(76.0%) patients, two surgeries were performed in 3 (12.0%)
patients.
All patients of Group III, who were treated with back-
ground drug therapy using osteoplastic material and antire-
sorptive drug, underwent classical Cieszyn´ski-Widmann-Neu-
mann surgery for the periodontium of the appropriate jaw,
namely 21 surgeries on the lower jaw and 5 surgeries on
the upper jaw. One surgery was performed in 22 (84.62%)
patients, two surgeries were performed in 3 (7.70%) patients.
Structural and functional state of bony tissue was studied
using markers of bony tissue metabolism in order to assess the
course of the disease and treatment effectiveness. One of the
bone formation markers is osteocalcin. Immunoenzymometric
test Nordic Bioscience Diagnostics A/S N-MID Osteocalcin
ELISA (Denmark) was applied to determine osteocalcin quan-
tity in blood serum. Its reference indices constitute 9.6-40.8
ng/ml in men, 8.4-33.9 ng/ml in women of perimenopausal
age, 9.5-48.3 ng/ml in postmenopausal women. Deoxypyridi-
noline is a specific and highly sensitive marker of resorption.
Deoxypyridinoline level in urine was determined according
to immunoenzyme method with the use of DPD EIA KIT
(USA). Reference indices constitute 3.0-7.4 n/mol for women
(25-44 years of age), 2.3-5.4 n/mol for men (25-55 years of
age). Clinical research was analyzed before the operation, on
the first, second, third, fourteenth day after the operation and
6 months after the surgery.
During the statistical analysis of the results, all the calcula-
tions were performed according to variation statistics method
with the use of STATISTICA, the application package of com-
puter program of medical and statistical calculations.
2. Results and discussion
Biochemical studies conducted in patients with GP and os-
teopenia in Group I revealed indices improvement after the
surgical treatment (Table 1).
According to the results of biochemical study, osteocalcin
level increased by 18.26% (p<0.05) and deoxypyridinoline
level decreased by 18.35% (p<0.05) in patients of Group I 3
months after the operation in comparison with the initial level
before the operation. Six months after the treatment, osteocal-
cin level increased by 22.02% (p<0.05) and deoxypyridino-
line level decreased by 41.07% (p<0.05) in patients of Group
I in comparison with the initial level before the operation.
This indicated their improvement compared to the initial level
before the operation. However, these indices were signifi-
cantly different from those in healthy people. Thus, surgical
treatment based on background therapy did not sufficiently
affect bony tissue mineralization in the remote postoperative
period.
The analysis of biochemical indices of patients in Group
II detected their positive dynamics (Table 2).
According to the results of biochemical study, osteocalcin
level increased by 25.94% (p<0.05) and deoxypyridinoline
level decreased by 30.49% (p<0.05) in patients of Group II 3
months after the operation in comparison with the initial level
before the operation. Six months after the treatment, osteo-
calcin level increased by 23.84% (p<0.05) and deoxypyridi-
noline level decreased by 54.06% (p<0.05) in patients of
Group II in comparison with the initial level before the opera-
tion. However, despite the positive dynamics of bony tissue
metabolism indices, they still did not reach the level of healthy
individuals.
Biochemical studies conducted in patients with GP and
osteopenia in Group III revealed indices improvement after
the surgical treatment (Table 3).
According to the results of biochemical study, osteocalcin
level increased by 30.60% (p<0.05) and deoxypyridinoline
level decreased by 35.82% (p<0.05) in patients of Group III 3
months after the operation in comparison with the initial level
before the operation. Six months after the treatment osteocal-
cin level increased by 53.13% (p<0.05) and deoxypyridino-
line level decreased by 65.17% (p<0.05) in patients of Group
III in comparison with the initial level before the operation.
This indicated their improvement as compared to the initial
level before the operation.
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Table 1. Dynamics of bony tissue metabolism indices in patients of Group I
Metabolism indices Healthy, n=22 Before the treatment, n=20 After the treatmentIn 3 months In 6 months
Osteocalcin, ng/ml 30.68±0.74 4 18.84± 0.85 23.05±0.08 * • 24.16±1.15 •
Deoxypyridinoline, n/mol 3.42±0.13 6.32±0.34 5.34±0.87 * • 4.48±1.64 •
Notes:
* - probability of difference from healthy individuals, p<0.05;
• - probability of difference before and after the treatment, p<0.05.
Table 2. Dynamics of bony tissue metabolism indices in patients of Group II
Metabolism indices Healthy, n=22 Before the treatment, n=20 After the treatmentIn 3 months In 6 months
Osteocalcin, ng/ml 30.68±0.74 18.67±0.83 25.21±0.12 * • 26.86±1.14 •
Deoxypyridinoline, n/mol 3.42±0.13 5.87±0.41 4.74±0.23 * • 3.81±0.42 •
Notes:
* - probability of difference from healthy individuals, p<0.05;
• - probability of difference before and after the treatment, p<0.05.
Table 3. Dynamics of bony tissue metabolism indices in patients of Group III
Metabolism indices Healthy, n=22 Before the treatment, n=20 After the treatmentIn 3 months In 6 months
Osteocalcin, ng/ml 30.68±0.54 18.96± 0.86 27.32±0.32 * • 29.54±1.09 •
Deoxypyridinoline, n/mol 3.42±0.13 5.88±0.31 3.84±0.54* • 3.68±1.14 •
Notes:
* - probability of difference from healthy individuals, p<0.05;
• - probability of difference before and after the treatment, p<0.05.
Biochemical indices remained the best in the patients of
Group III in comparison with patients in Groups I and Group
II in all periods after treatment.
Surgical treatment with the use of osteoplastic material
and antiresorptive drug contributed to the most significant
positive effect on changes in biochemical indices in patients
with GP and osteopenia.
3. Conclusions
1. Positive dynamics of biochemical indices of osteocalcin
and deoxypyridinoline was observed in patients with
GP and osteopenia after surgical treatment based on the
background therapy. Surgical treatment based on the
background therapy did not provide sufficient stabiliza-
tion of GP biochemical manifestations in the remote
postoperative period.
2. The use of ”Easy Graft” osteoplastic material in the
surgical treatment of patients with GP and osteopenia
promotes positive dynamics of biochemical indices of
osteocalcin and deoxypyridinoline.
3. The combined use of osteoplastic material ”Easy Graft”
and antiresorptive drug ”Bonviva” leads to process sta-
bilization being confirmed by biochemical indices of
osteocalcin and deoxypyridinoline both in early and
remote postoperative periods.
4. The developed regimen of surgical treatment of patients
with chronic II and III stage GP and osteopenia in com-
bination with pharmacological therapy increasing sur-
gical treatment efficiency and promoting stabilization
process is safe and accessible in dentist’s practice.
4. Prospects for further research
Taking into account high GP prevalence, the issue of further
study of osteoplastic material ”Easy Graft” and antiresorptive
drug ”Bonviva” impact on densitometric manifestations both
in early and remote postoperative period becomes relevant.
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